From Foe to Friend: Viruses Show New Promise as Cancer Treatment

Updated Oct. 28, 2015

Almost as long as scientists have known of the existence of viruses, they’ve dreamed of using the tiny pathogens as a weapon against cancer. Now, as a result of advances in genetic engineering and insights into the workings of the immune system, science is giving substance to the dream.

A variety of studies over the past few years have demonstrated the ability of specially modified viruses to attack and kill cancer cells – in the laboratory and, very recently, in some patients. Techniques vary from study to study, but the basic approach is to inject the viruses directly into tumors – allowing the virus to infect and kill many of the cancer cells and, equally important, to stimulate the immune system to launch its own assault on the tumor.

One high-profile example of this approach, reported recently on CBS News’ “60 Minutes,” involved researchers at Duke University who treated patients with glioblastoma with a modified polio virus. In a small, early study, 11 of 22 patients showed substantial improvement from the regimen.

viruses show new promise as cancer treatment

Harvey Cantor, MD, chair of Dana-Farber’s Department of Immunology and AIDS

Other research attracting journalistic attention is a clinical trial at the Mayo Clinic that uses the measles virus to treat patients with multiple myeloma. Investigators found that after infecting cancer cells, the virus causes them to clump together and disintegrate. The wreckage may trigger an immune system response that can prevent the disease from returning for a long period of time, researchers have suggested.

At Dalhousie University in Halifax, Nova Scotia, scientists have shown that reoviruses – common, benign viruses often found in the respiratory tract – can be engineered to specifically infect melanoma cells. The infection appears to prompt an immune system attack that kills not only the infected cells but also the uninfected cancer cells nearby. In early-stage clinical trials, the treatment has been shown to be effective in some patients with melanoma and, when coupled with chemotherapy, in some patients with head and neck cancers.

“There have been efforts to use viruses in cancer therapy for more than 50 years, but we now have more of a grasp of what’s going on, and why some viruses work better than others,” says Harvey Cantor, MD, chair of Dana-Farber’s Department of Immunology and AIDS. A key component to this understanding, Cantor says, is that the impact of the virus should not only kill the tumor cells, but it should also initiate a T cell immune response that destroys the primary tumor as well as metastases.

Cantor says researchers are also looking at combining this treatment approach with immune-checkpoint inhibitors, which can help “take the brakes off” the immune system and enhance the patient’s anti-tumor response.

“It’s a treatment concept that is very interesting and certainly has a lot of promise,” Cantor says.

Update – Oct. 28, 2015: The FDA has approved the first virus-based cancer treatment, Imlygic (talimogene laherparepvec), which is used to treat advanced-stage melanoma. The treatment is a modified version of  the herpes virus that attacks the cancer and launches an immune system response against tumors. In a clinical trial of 436 patients treated with Imlygic, 16 percent saw tumors shrink for at least six months.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Latest Tweets

Dana-Farber @danafarber
In some patients, even with advanced cancers, #immunotherapy treatments have slowed or halted the disease after sta… https://t.co/dMZLWqP1yn
Dana-Farber @danafarber
Treatment with #immunotherapy drugs hasn’t yet been approved for small cell #lungcancer, but some early findings in… https://t.co/zT6BVl24p1
Dana-Farber @danafarber
Going through #braincancer treatment at age 24, Alex Berking is experiencing a new connection to her late father –… https://t.co/r33zdAsKo8

Patient and Family Blogs

Patients and families of patients at Dana-Farber often chronicle their own experiences with cancer.

Here are some blogs that you can follow.